| TB all locations | ROC | 71.72% | Obs | 147 | IC | 0.63 - 0.80 |
| Cutpoint | ≥24.06 | Sensitivity | 71.92% | Specificity | 68.89% | |
| Cutpoint | ≥37.17 | Sensitivity | 52.63% | Specificity | 81.11% | |
| Patients with HIV infection <200 CD4 cells-TB all locations | ROC | 73.51% | obs | 76 | IC | 0.61 - 0.85 |
| Cutpoint | ≥21.78 | Sensitivity | 79.55% | Specificity | 68.75% | |
| Cutpoint | ≥26.2 | Sensitivity | 70.45% | Specificity | 71.88% | |
| Cutpoint | ≥29.50 | Sensitivity | 61.26% | Specificity | 75.00% | |
| Patients with HIV infection >200 CD4 cells-TB all locations | ROC | 70.28% | obs | 83 | IC | 0.58 - 0.83 |
| Cutpoint | ≥24.6 | Sensitivity | 72.00% | Specificity | 68.97% | |
| Pulmonary TB | ROC | 75.15% | obs | 128 | IC | 0.66 - 0.84 |
| Cutpoint | ≥21.78 | Sensitivity | 78.95% | Specificity | 65.56% | |
| Cutpoint | ≥24.06 | Sensitivity | 76.32% | Specificity | 68.89% |